Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molcan is a Canadian-based life sciences company specializing in the development and manufacture of high-quality Active Pharmaceutical Ingredients (APIs), pharmaceutical reference standards, and impurities. The company provides a wide range of products including stable isotope-labeled compounds, metabolites, and controlled substances to support the global pharmaceutical and biotech industries. Molcan offers custom synthesis services and contract research and manufacturing (CDMO) capabilities, focusing on complex small molecule chemistry. Their expertise spans various therapeutic areas such as oncology, cardiovascular diseases, and infectious diseases, serving both generic and innovative drug developers. The company is recognized for its ability to synthesize difficult-to-find impurities and provide comprehensive analytical documentation for regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molcan.